Tag Archive for: donanemab

Eli Lilly and Company's headquarters © Momoneymoproblemz/wikimedia com
Alzheimer's

Lilly presents impressing results for Alzheimer’s drug donanemab

Eli Lilly’s Alzheimer’s drug donanemab has speedy removed amyloid plaques in a pivotal Phase III trail halting disease progression for one year in half of patients.

Read more